Generation of the induced pluripotent stem cell line SJTUGHi004-A derived from a Best’s disease patient with c.763C > T mutation in BEST1 gene
Best's disease (BD), referred to as Best vitelliform macular dystrophy, is an autosomal dominant macular degeneration caused by mutations in the BESTROPHIN1 (BEST1) gene. Here, we generated an induced pluripotent stem cell (iPSC) line by the non-integrative Sendai-virus delivery system derived from peripheral blood mononuclear cells (PBMCs) of a patient with c.763C > T mutation in the BEST1 gene. The iPSC line was characterized and validated for the karyotype stability, pluripotency markers, and differentiation potential in vitro, which may serve as a powerful model for exploring the pathological mechanism and pharmaceutical development.
Authors
- Xiaodong Sun (ORCID: https://orcid.org/0000-0001-5015-0945)
- Yuxin Jiang
- Guanran Zhang (ORCID: https://orcid.org/0000-0002-0744-1955)
- Tong Li (ORCID: https://orcid.org/0000-0002-8988-234X)
- Hong Wang (ORCID: https://orcid.org/0000-0001-6905-438X)
- Xueli Chen (ORCID: https://orcid.org/0000-0003-4246-5183)
- Lihong Jiang (ORCID: https://orcid.org/0000-0002-5759-2903)
- Jieqiong Chen (ORCID: https://orcid.org/0000-0003-1673-6517)
- Mei Jiang (ORCID: https://orcid.org/0009-0004-4793-5759)
Institutions
- Shanghai Eye Disease Prevention & Treatment Center (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- Stem Cell Research
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1016/j.scr.2025.103806
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00